Cellectar Biosciences, Inc. (CLRB) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2002: $599.4K2003: $388.9K2004: $46.2K2005: $400.2K2006: $6.55M2007: $2.53M2008: $9.84M2009: $4.13M2010: $133.8K2011: $9.48M2012: $10.16M2013: $1.70M2014: $6.70M2015: $1.65M2016: $13.54M2017: $10.75M2018: $13.26M2019: $9.06M2020: $54.79M2021: $29.06M2022: $8.15M2023: -$15.16M2024: $14.29M2025: $8.54M$8.54M
2002Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$8.54M-40.3%
2024$14.29M+194.3%
2023-$15.16M-285.9%
2022$8.15M-71.9%
2021$29.06M-47.0%
2020$54.79M+504.8%
2019$9.06M-31.7%
2018$13.26M+23.3%
2017$10.75M-20.6%
2016$13.54M+720.7%
2015$1.65M-75.4%
2014$6.70M+294.1%
2013$1.70M-83.3%
2012$10.16M+7.1%
2011$9.48M+6988.1%
2010$133.8K-96.8%
2009$4.13M-58.1%
2008$9.84M+289.7%
2007$2.53M-61.4%
2006$6.55M+1535.7%
2005$400.2K+766.7%
2004$46.2K-88.1%
2003$388.9K-35.1%
2002$599.4K